These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35131532)

  • 1. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial.
    Cagnacci A; Barattini DF; Casolati E; Pecoroni A; Mangrella M; Patrascu LC
    Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():239-245. PubMed ID: 35131532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
    De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
    Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short and long-term effect of polycarbophil vaginal gel on vaginal atrophy of peri- and post-menopausal women. The TRIPLE study.
    Cagnacci A; Franco Barattini D; Casolati E; Mangrella M; Piccolo E; Piazza R; Pecoroni A; Rosu S; Cristian Pătrașcu L
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():303-308. PubMed ID: 38950453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study.
    Galli V; Golia D'Augè T; DI Pierro F; Cazzaniga M; Guasti L; Zerbinati N; Bertuccioli A; Khan A; D'Ovidio G; Iaculli F; Tibaldi V; Santangelo G; Fischetti M; Casorelli AF; DI Donato V; Giannini A; Musella A; Giancotti A; Monti M
    Minerva Obstet Gynecol; 2024 Aug; 76(4):343-352. PubMed ID: 38358384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
    Garcia de Arriba S; Grüntkemeier L; Häuser M; May TW; Masur C; Stute P
    PLoS One; 2022; 17(5):e0266633. PubMed ID: 35551533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial.
    Stute P; May TW; Masur C; Schmidts-Winkler IM
    Climacteric; 2015; 18(4):582-9. PubMed ID: 25845406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
    Carter J; Baser RE; Goldfrank DJ; Seidel B; Milli L; Stabile C; Canty J; Saban S; Goldfarb S; Dickler MN; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
    Support Care Cancer; 2021 Jan; 29(1):311-322. PubMed ID: 32358778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
    Chen J; Geng L; Song X; Li H; Giordan N; Liao Q
    J Sex Med; 2013 Jun; 10(6):1575-84. PubMed ID: 23574713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nettle vaginal cream on subjective symptoms of vaginal atrophy in postmenopausal women.
    Karimi FZ; Nazari N; Rakhshandeh H; Mazloum SR
    Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():41-45. PubMed ID: 37044017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
    Chatsiproios D; Schmidts-Winkler IM; König L; Masur C; Abels C
    PLoS One; 2019; 14(1):e0210967. PubMed ID: 30677065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.
    Archer DF; Goldstein SR; Simon JA; Waldbaum AS; Sussman SA; Altomare C; Zhu J; Yoshida Y; Schaffer S; Soulban G
    Menopause; 2019 Jan; 26(6):611-621. PubMed ID: 30694917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.
    Villa P; Tagliaferri V; Amar ID; Cipolla C; Ingravalle F; Scambia G; Ricciardi W; Lanzone A
    Gynecol Endocrinol; 2020 Jun; 36(6):535-539. PubMed ID: 31847628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study.
    Berreni N; Salerno J; Chevalier T; Alonso S; Mares P
    BMC Womens Health; 2021 Aug; 21(1):322. PubMed ID: 34454465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
    Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
    Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of prolonged-release hyaluronic acid derivative vaginal application in the postpartum period: a prospective randomised clinical trial.
    Gustavino C; Sala P; Cusini N; Gravina B; Ronzini C; Marcolin D; Vellone VG; Paudice M; Nappi R; Costantini S; Ferrero S; Barra F
    Ann Med; 2021 Dec; 53(1):1589-1597. PubMed ID: 34477473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women.
    Tersigni C; Di Simone N; Tempestilli E; Cianfrini F; Russo R; Moruzzi MC; Amar ID; Fiorelli A; Scambia G; Villa P
    J Obstet Gynaecol; 2015; 35(8):835-8. PubMed ID: 25968636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.